| 1 |
Rahimi F, Rezayatmand R, Shojaeenejad J, Tabesh E, Ravankhah Z, Adibi P. Costs and outcomes of colorectal cancer screening program in Isfahan, Iran. BMC Health Serv Res 2023;23:13. [PMID: 36604670 DOI: 10.1186/s12913-022-09010-1] [Reference Citation Analysis]
|
| 2 |
Coury J, Ramsey K, Gunn R, Judkins J, Davis M. Source matters: a survey of cost variation for fecal immunochemical tests in primary care. BMC Health Serv Res 2022;22:204. [PMID: 35168616 DOI: 10.1186/s12913-022-07576-4] [Reference Citation Analysis]
|
| 3 |
Law J, Rajan A, Trieu H, Azizian J, Berry R, Beaven SW, Tabibian JH. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Dig Dis Sci 2022;67:2842-8. [PMID: 34350518 DOI: 10.1007/s10620-021-07160-6] [Reference Citation Analysis]
|
| 4 |
Morain SR, Mathews DJH, Geller G, Bollinger J, Weinfurt K, Jarvik JG, May E, Sugarman J. Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research. Healthc (Amst) 2021;9:100586. [PMID: 34600345 DOI: 10.1016/j.hjdsi.2021.100586] [Reference Citation Analysis]
|
| 5 |
Mallafré-Muro C, Llambrich M, Cumeras R, Pardo A, Brezmes J, Marco S, Gumà J. Comprehensive Volatilome and Metabolome Signatures of Colorectal Cancer in Urine: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:2534. [PMID: 34064065 DOI: 10.3390/cancers13112534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Pickhardt PJ, Correale L, Hassan C. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests. AJR Am J Roentgenol 2021;217:817-30. [PMID: 33703913 DOI: 10.2214/AJR.20.25416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Ferlizza E, Solmi R, Sgarzi M, Ricciardiello L, Lauriola M. The Roadmap of Colorectal Cancer Screening. Cancers (Basel) 2021;13:1101. [PMID: 33806465 DOI: 10.3390/cancers13051101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 8 |
Bollinger JM, Geller G, Weinfurt K, May E, Morain SR, Mathews DJH, Sugarman J. Patients' Views About the Disclosure of Collateral Findings in Pragmatic Clinical Trials: a Focus Group Study. J Gen Intern Med 2020;35:3436-42. [PMID: 32815061 DOI: 10.1007/s11606-020-06113-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Morain SR, Mathews DJH, Weinfurt K, May E, Bollinger JM, Geller G, Sugarman J. Stakeholder perspectives regarding pragmatic clinical trial collateral findings. Learn Health Syst 2021;5:e10245. [PMID: 34667872 DOI: 10.1002/lrh2.10245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 10 |
Bell D. Faecal immunochemical test. Radiopaedia.org 2020. [DOI: 10.53347/rid-79650] [Reference Citation Analysis]
|
| 11 |
O'Connor EA, Nielson CM, Petrik AF, Green BB, Coronado GD. Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep 2020;10:2441. [PMID: 32051454 DOI: 10.1038/s41598-020-59032-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 12 |
Whicher DM, Wu AW. Collateral Findings from Pragmatic Clinical Trials: What Responsibility Do We Have to Enrolled and Future Patients? Am J Bioeth 2020;20:21-4. [PMID: 31896336 DOI: 10.1080/15265161.2019.1687790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 13 |
Morain SR, Weinfurt K, Bollinger J, Geller G, Mathews DJ, Sugarman J. Ethics and Collateral Findings in Pragmatic Clinical Trials. Am J Bioeth 2020;20:6-18. [PMID: 31896322 DOI: 10.1080/15265161.2020.1689031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 14 |
Coronado GD, Green BB, West II, Schwartz MR, Coury JK, Vollmer WM, Shapiro JA, Petrik AF, Baldwin LM. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer 2020;126:540-8. [PMID: 31658375 DOI: 10.1002/cncr.32567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 15 |
Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, Rivelli JS, Kapka TJ, Meenan RT, Mummadi RR, Green BB, Coronado GD. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med 2018;7:4781-90. [PMID: 30101513 DOI: 10.1002/cam4.1727] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
